Formosa Pharmaceuticals, Inc. 6838.TWO Stock
Formosa Pharmaceuticals, Inc. Price Chart
Formosa Pharmaceuticals, Inc. 6838.TWO Financial and Trading Overview
| Formosa Pharmaceuticals, Inc. stock price | 54.8 TWD |
| Previous Close | 58.5 TWD |
| Open | 58.9 TWD |
| Bid | 59.5 TWD x N/A |
| Ask | 59.9 TWD x N/A |
| Day's Range | 58.7 - 60 TWD |
| 52 Week Range | 33.4 - 70 TWD |
| Volume | 248.41K TWD |
| Avg. Volume | 370.92K TWD |
| Market Cap | 20.88B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.59 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6838.TWO Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 29.899498 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Formosa Pharmaceuticals, Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 72.14% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 70 TWD |
| 52 Week Low | 33.4 TWD |
| 50-Day Moving Average | 59.89 TWD |
| 200-Day Moving Average | 56.39 TWD |
6838.TWO Share Statistics
| Avg. Volume (3 month) | 370.92K TWD |
| Avg. Daily Volume (10-Days) | 184.53K TWD |
| Shares Outstanding | 350.95M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 333K TWD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -3.69 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 1.99 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Formosa Pharmaceuticals, Inc.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 57, Fuxing North Road |
| ZIP | 105 |
| Phone | 886 2 2755 7659 |
| Website | https://www.formosapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Formosa Pharmaceuticals, Inc., a late-preclinical and early clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan. It is involved in developing APP13007, an aqueous-based ophthalmic nanosuspension that is in Phase III clinical trial for the treatment of post-operative pain and inflammatory eye conditions; TSY-0110, an antibody-drug conjugate; and TSY-0210, an antibiotic for drug resistant infections. The company also develops APP13002, a topical antibiotic for infectious eye diseases, such as blepharitis; and MPT0E028, a novel pan- histone deacetylase inhibitor for solid tumors, such as hepatomas and colorectal cancer, as well as lung fibrosis. It has a collaboration agreement with Eyenovia, Inc. for the development of novel ophthalmic therapeutic. The company was founded in 2010 and is headquartered in Taipei City, Taiwan.
Q&A For Formosa Pharmaceuticals, Inc. Stock
What is a current 6838.TWO stock price?
Formosa Pharmaceuticals, Inc. 6838.TWO stock price today per share is 54.8 TWD.
How to purchase Formosa Pharmaceuticals, Inc. stock?
You can buy 6838.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Formosa Pharmaceuticals, Inc.?
The stock symbol or ticker of Formosa Pharmaceuticals, Inc. is 6838.TWO.
Which industry does the Formosa Pharmaceuticals, Inc. company belong to?
The Formosa Pharmaceuticals, Inc. industry is Biotechnology.
How many shares does Formosa Pharmaceuticals, Inc. have in circulation?
The max supply of Formosa Pharmaceuticals, Inc. shares is 134.14M.
What is Formosa Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
Formosa Pharmaceuticals, Inc. PE Ratio is now.
What was Formosa Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
Formosa Pharmaceuticals, Inc. EPS is -2.59 TWD over the trailing 12 months.
Which sector does the Formosa Pharmaceuticals, Inc. company belong to?
The Formosa Pharmaceuticals, Inc. sector is Healthcare.